RSS   Newsletter   Contact   Advertise with us
Post Online Media

NightstaRx appoints Senthil Sundaram as CFO

NightstaRxNightstaRx, a biopharmaceutical company, announced that Senthil Sundaram has joined the company as chief financial officer.

Prior to joining Nightstar, Mr. Sundaram was the Vice President and Head of Business and Corporate Development at Intercept Pharmaceuticals.

While at Intercept, Mr. Sundaram was highly ranked on the Institutional Investor Magazine’s survey for the Biotechnology All-America Executive Team.

Prior to joining Intercept, he spent 13 years in the healthcare investment banking groups at Lehman Brothers/Barclays, Citigroup and Lazard.

His transaction experience includes mergers & acquisitions, initial public offerings and other equity and debt financings in the biopharmaceuticals sector.

Mr. Sundaram is a graduate of Brown University, where he obtained degrees in Computer Engineering and Economics.

 LATEST MOVES FROM Massachusetts 

More inside POST

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy